291 related articles for article (PubMed ID: 21517759)
1. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
2. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
5. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
6. Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.
Jortzik E; Zocher K; Isernhagen A; Mailu BM; Rahlfs S; Viola G; Wittlin S; Hunt NH; Ihmels H; Becker K
Antimicrob Agents Chemother; 2016 Jan; 60(1):115-25. PubMed ID: 26459907
[TBL] [Abstract][Full Text] [Related]
7. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.
Freewan M; Rees MD; Plaza TS; Glaros E; Lim YJ; Wang XS; Yeung AW; Witting PK; Terentis AC; Thomas SR
J Biol Chem; 2013 Jan; 288(3):1548-67. PubMed ID: 23209301
[TBL] [Abstract][Full Text] [Related]
8. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
9. Interactions between nitric oxide and indoleamine 2,3-dioxygenase.
Samelson-Jones BJ; Yeh SR
Biochemistry; 2006 Jul; 45(28):8527-38. PubMed ID: 16834326
[TBL] [Abstract][Full Text] [Related]
10. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
12. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.
Thomas SR; Stocker R
Redox Rep; 1999; 4(5):199-220. PubMed ID: 10731095
[TBL] [Abstract][Full Text] [Related]
13. A specific interaction of L-tryptophan with CO of CO-bound indoleamine 2,3-dioxygenase identified by resonance Raman spectroscopy.
Yanagisawa S; Sugimoto H; Shiro Y; Ogura T
Biochemistry; 2010 Nov; 49(47):10081-8. PubMed ID: 21028817
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase.
Sugimoto H; Oda S; Otsuki T; Hino T; Yoshida T; Shiro Y
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2611-6. PubMed ID: 16477023
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
16. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
17. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
[TBL] [Abstract][Full Text] [Related]
20. UV Resonance Raman Characterization of a Substrate Bound to Human Indoleamine 2,3-Dioxygenase 1.
Yanagisawa S; Kayama K; Hara M; Sugimoto H; Shiro Y; Ogura T
Biophys J; 2019 Aug; 117(4):706-716. PubMed ID: 31405517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]